Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Import alert on bulk glycerin

This article was originally published in The Tan Sheet

Executive Summary

Import alert on bulk glycerin: FDA calls for increased surveillance of glycerin from China in an Aug. 1 import alert issued after acetaminophen elixir manufactured using glycerin contaminated with diethylene glycol, an anti-freeze ingredient, poisoned and killed dozens of children in Haiti. Bulk glycerin from sources potentially relaying shipments from China also may be checked for the contaminant, the alert says. Glycerin is used in a number of products, including lozenges and suppositories, soaps, and moisturizer in cosmetics, the alert notes. No shipments of glycerin from China have been received in the U.S. this year, according to U.S. Customs Service data...

You may also be interested in...



FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance

Pharmaceutical manufacturing facilities and compounding pharmacists should include tests for diethylene glycol content in the identity testing of all lots of glycerin they receive, according to an FDA guidance reflecting growing concern about vulnerabilities in the global supply chain

FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance

Pharmaceutical manufacturing facilities and compounding pharmacists should include tests for diethylene glycol content in the identity testing of all lots of glycerin they receive, according to an FDA guidance reflecting growing concern about vulnerabilities in the global supply chain

FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance

Pharmaceutical manufacturing facilities and compounding pharmacists should include tests for diethylene glycol content in the identity testing of all lots of glycerin they receive, according to an FDA guidance reflecting growing concern about vulnerabilities in the global supply chain

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085884

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel